Literature DB >> 1848040

Cytomegalovirus nucleic acid distribution within the human vascular tree.

M G Hendrix1, M Daemen, C A Bruggeman.   

Abstract

The presence of human cytomegalovirus (HCMV) nucleic acids was demonstrated in almost all major arteries of HCMV-seropositive patients by polymerase chain reaction. The amount of HCMV nucleic acids present in the arterial wall was calculated to be less than 2 viral genomic equivalents per 2500 human genomic equivalents. No relation was observed between the presence of HCMV nucleic acids in the arterial wall and the existence of atherosclerotic changes. No differences were observed in the number of viral genomic equivalents present at sites with or without atherosclerosis. Apart from a role for HCMV in the pathogenesis of atherosclerosis, the presence of latent HCMV in the arterial tree provides a powerful system to describe the physical state of this latently present virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848040      PMCID: PMC1886290     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Herpesviridae in the coronary arteries and aorta of young trauma victims.

Authors:  H M Yamashiroya; L Ghosh; R Yang; A L Robertson
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  The structure of the major immediate early gene of human cytomegalovirus strain AD169.

Authors:  A Akrigg; G W Wilkinson; J D Oram
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

Review 3.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

4.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Molecular cloning and restriction endonuclease mapping of the rat cytomegalovirus genome.

Authors:  H Meijer; J C Dreesen; C P Van Boven
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

6.  Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals.

Authors:  M A McVoy; S P Adler
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

7.  The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients.

Authors:  M G Hendrix; P H Dormans; P Kitslaar; F Bosman; C A Bruggeman
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

8.  Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues.

Authors:  C B Toorkey; D R Carrigan
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

Review 9.  The pathogenesis of atherosclerosis: atherogenesis and inflammation.

Authors:  J M Munro; R S Cotran
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

10.  Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus.

Authors:  A M van Loon; F W Heessen; J T van der Logt; J van der Veen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

View more
  19 in total

1.  An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.

Authors:  S Tugizov; E Maidji; J Xiao; L Pereira
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

3.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Immortalization of primary human smooth muscle cells.

Authors:  N Perez-Reyes; C L Halbert; P P Smith; E P Benditt; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

Review 6.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

7.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.

Authors:  Y F Zhou; E Guetta; Z X Yu; T Finkel; S E Epstein
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

8.  Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

Authors:  Lenore Pereira; Matthew Petitt; Alex Fong; Mitsuru Tsuge; Takako Tabata; June Fang-Hoover; Ekaterina Maidji; Martin Zydek; Yan Zhou; Naoki Inoue; Sanam Loghavi; Samuel Pepkowitz; Lawrence M Kauvar; Dotun Ogunyemi
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

9.  Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims.

Authors:  R M Hendrix; M Wagenaar; R L Slobbe; C A Bruggeman
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

10.  Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.

Authors:  P Koskinen; K Lemström; C Bruggeman; I Lautenschlager; P Häyry
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.